Yahoo
OTC Markets OTCID USD

Curative Biotechnology, Inc. (CUBT)

0.8300 0.0000 (0.00%)
As of November 9 at 4:00:00 PM EST. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2022
12/31/2021
Total Revenue
0 0 0
Cost of Revenue
0 0 0
Gross Profit
0 0 0
Selling, General and Administrative Expenses
-1,610.0120 -1,945.6530 -4,211.3550
Research and Development Expenses
-2,184.1640 -2,482.0790 -779.2750
Depreciation, Amortization and Depletion
-7.9560 -7.9560 -6.7440
Operating Income/Expenses
-3,802.1320 -4,435.6880 -4,997.3740
Total Operating Profit/Loss
-3,802.1320 -4,435.6880 -4,997.3740
Total Net Finance Income/Expense
-1,373.4950 -1,170.3190 -176.6720
Irregular Income/Expenses
-3.8000 -3.8000 -166.3080
Other Income/Expense, Non-Operating
4.9140 4.9140 0
Non-Operating Income/Expenses, Total
-1,372.3810 -1,169.2050 -342.9800
Pretax Income
-5,174.5130 -5,604.8930 -5,340.3540
Net Income from Continuing Operations
-5,174.5130 -5,604.8930 -5,340.3540
Net Income after Extraordinary Items and Discontinued Operations
-5,174.5130 -5,604.8930 -5,340.3540
Net Income after Non-Controlling/Minority Interests
-5,174.5130 -5,604.8930 -5,340.3540
Net Income Available to Common Stockholders
-5,174.5130 -5,604.8930 -5,340.3540
Diluted Net Income Available to Common Stockholders
-5,174.5130 -5,604.8930 -5,340.3540
Basic EPS
-1.34 -1.50 -1.57
Diluted EPS
-1.34 -1.50 -1.57
Basic Weighted Average Shares Outstanding
3,805.2230 3,813.3990 3,402.1570
Diluted Weighted Average Shares Outstanding
3,805.2230 3,813.3990 3,402.1570
Income Statement, Supplemental
EBIT
-3,801.0180 -4,434.5740 -5,163.6820
EBITDA
-3,793.0620 -4,426.6180 -5,156.9380
Normalized EBITDA
-3,726.0150 -4,144.0140 -2,101.0630
Normalized Income
-5,107.4660 -5,322.2890 -2,284.4790
Total Unusual Items
67.0470 282.6040 3,055.8750
Total Unusual Items Excluding Goodwill
67.0470 282.6040 3,055.8750
Tax Effect of Unusual Items
0 0 0
12/31/2021 - 3/30/1998

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: